D-chiro-inositol and Endometrial Thickness

Lo.Li.Pharma

Status: Completed

Conditions: Endometrial Diseases

Treatments: Dietary Supplement: DCI

Study type: Interventional

Funder types: Industry

Identifiers

NCT05283642

DCI_GYN22

Details and patient eligibility

About

Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.

Enrollment: 13 patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• altered endometrial thickness

Exclusion criteria

• patients with cancer
• patients under hormonal treatments (progestogens and/or estrogens)
• patients supplemented with inositols

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

13 participants in 1 patient group

DCI

Experimental group

Description:

Oral supplementation with D-chiro-inositol once a day

Treatment:

Dietary Supplement: DCI